Towards evidence based medicine for paediatricians: Question 2 - Is intravenous immunoglobulin superior to exchange transfusion in the management of hyperbilirubinaemia in term neonates?

Archives of Disease in Childhood

Volumn 94, Issue 9, 2009, Pages 739-741

  Walsh, Sandra ^a   Molloy, Eleanor J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ANAPHYLAXIS; CLINICAL TRIAL; DRUG HYPERSENSITIVITY; EXCHANGE BLOOD TRANSFUSION; FETUS HYDROPS; FRAGILE X SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERBILIRUBINEMIA; HYPOCALCEMIA; HYPOGLYCEMIA; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEWBORN HEMOLYTIC DISEASE; NOTE; PERINATAL MORTALITY; PHOTOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; STRUCTURED QUESTIONNAIRE; THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

EVIDENCE-BASED MEDICINE; EXCHANGE TRANSFUSION, WHOLE BLOOD; HUMANS; HYPERBILIRUBINEMIA; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; TREATMENT OUTCOME;

EID: 69249146622     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.159004     Document Type: Note

References (26)

1. Clarke CA, Mollison PL, Whitfield AG. Deaths from rhesus haemolytic disease in England and Wales in 1982 and 1983. BMJ 1985;291:17-19.
2. Ip S, Chung M, Kulig J, et al. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316.
3. Patra K. Adverse events associated with neonatal exchange transfusion in the 1990s. J Pediatr 2004;144:626-631 (Pubitemid 38594764)
4. Sato K, Hara T, Kondo T, et al. High-dose intravenous gammaglobulin therapy for neonatal immune haemolytic jaundice due to blood group incompatibility. Acta Paediatr Scand 1991;80:163-166
5. Urbaniak SJ. ADCC (K-cell) lysis of human erythrocytes sensitized with rhesus alloantibodies. II. Investigation into the mechanism of lysis. Br J Haematol 1979;42:315-325
6. Gottstein R, Cooke RWI. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 2003;88:F6-F10. (Pubitemid 36084200)
7. Alcock GS, Liley H. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database Syst Rev 2002;(3):CD003313.
8. Nasseri R, Mamouri GA, Babaei H. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn. Saudi Med J 2006;27:1827-1830 (Pubitemid 351863312)
9. Voto LS, Sexer H, Ferreiro G, et al. Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic disease. J Perinat Med 1995;23:443-451 (Pubitemid 26052734)
10. Rübo J, Albrecht K, Lasch P, et al. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. J Pediatr 1992;121:93-97
11. Tanyer G, Siklar Z, Dallar Y, et al. Multiple dose IVIG treatment in neonatal immune hemolytic jaundice. J Trop Pediatr 2001;47:50-53 (Pubitemid 32170937)
12. YapPL. Intravenous immunoglobulin and hepatitis C virus: an overview of transmission episodes with emphasis on manufacturing data. Clin Ther 1996;18:43-58.
13. Alpay F, Sarici SÜ, Okutan V, et al. High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. Acta Paediatr 1999;88:216-219 (Pubitemid 29124328)
14. Mukhopadhyay K, Murki S, Narang A, et al. Intravenous immunoglobulins in rhesus hemolytic disease. Indian J Pediatr 2003;70:697-699 (Pubitemid 37295912)
15. Hammerman C, Vreman HJ, Kaplan M, et al. Intravenous immune globulin in neonatal immune hemolytic disease: does it reduce hemolysis? Acta Paediatr 1996;85:1351-1353
16. Walsh SA, Yao N, El-Khuffash A, et al. Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn. Ir Med J 2008;101:46-48
17. Aggarwal R, Seth R, Paul VK, et al. High dose intravenous immunoglobulin therapy in the treatment of rhesus hemolytic disease. J Trop Pediatr 2002;48:116-117 (Pubitemid 34461037)
18. Ergaz Z, Gross D, Bar-Oz B, et al. Carboxyhemoglobin levels in neonatal immune hemolytic jaundice treated with intravenous gammaglobulin. Vox Sang 1995;69:95-99
19. Aylin T, Berkan G. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease. Indian Pediatr 2005;42:77-79
20. Sebag O, Sirvent N, Dupuy M, et al. Severe newborn icterus due to Rhesus incompatibility. Treatment with intravenous immunoglobulins. Arch Pediatr 1999;6:345.
21. Mundy CA. Intravenous immunoglobulin in the management of hemolytic disease of the newborn. Neonatal Netw 2005;24:17-24.
22. Merchant RH, Pradeep S. Intravenous immunoglobulin therapy for hyperbilirubinemia caused by Rhesus hemolytic disease. Indian Pediatr 1994;31:1269-1271 (Pubitemid 24327158)
23. NHS. Clinical guidelines for immunoglobulin use. 2nd edn. London: Department of Health, June 2008. See http://www.library.nhs.uk/GUIDELINESFINDER/ ViewResource.aspx?resID=289918 (accessed 26 June 2009).
24. Miqdad AM, Abdelbasit OB, Shaheed MM. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn. J Matern Fetal Neonatal Med 2004;16:163-166
25. Dagoglu T, Ovali F, Samaci N, et al. High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease. J Int Med Res 1995;23:264-271
26. Hofstadler G, Hohenauer L. High dosage immunoglobulin therapy in Rhesus incompatibility. Klin Padiatr 1995;207:103-105